The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Type 2 diabetes mellitus, cognitive impairment and dementia
Abstract
Summary: Aims We set out to examine the evidence for an association between cognitive impairment or dementia and the presence of Type 2 diabetes mellitus (DM). We also sought evidence of potential mechanisms for such an association. Methods A literature search of three databases was performed and the reference lists of the papers so identified were examined, using English language papers only. Results We found evidence of cross‐sectional and prospective associations between Type 2 DM and cognitive impairment, probably both for memory and executive function. There is also evidence for an elevated risk of both vascular dementia and Alzheimer’s disease in Type 2 DM albeit with strong interaction of other factors such as hypertension, dyslipidaemia and apolipoprotein E phenotype. Both vascular and non‐vascular factors are likely to play a role in dementia in diabetes. Conclusions Current classification structures for dementia may not be adequate in diabetes, where mixed pathogenesis is likely. Further research into the mechanisms of cognitive impairment in Type 2 DM may allow us to challenge the concept of dementia, at least in these patients, as an irremediable disease. Diabet. Med. 16, 93–112 (1999)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a growing literature indicating that individuals with diabetes have impairments in recent memory (3–6).”
From Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly (2003) · cites this paper as [4]
In the citing paper
“However, many of these studies were cross-sectional and were thus unable to provide estimates of diabetes as a risk factor for future cognitive dysfunction.”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“Recent evidence from several epidemiological studies suggests that it is also a risk factor for cognitive dysfunction [3 -6].”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“Indeed, only one [7] of the review articles that summarised the available data pertaining to this relationship [4, 6 -11] provided a quantitative estimate.”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“These findings are supported by previous reviews of the available longitudinal studies [3, 4, 6].”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,162
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Research works printed but not linked: 8
- Jagusch W, 1992, Cognitive function and metabolic state in elderly diabetic patients., Diab Nutr Metab., 5, 265
- Breteler MmB.Cognitive Decline in the Elderly.Published Thesis ISBN 90–90006241–6.1993.
- Amato L, 1996, Non‐insulin‐dependent diabetes mellitus is associated with a greater prevalence of depression in the elderly., Diabetes Metab., 22, 314
- Kokeman E, 1960, Dementia after ischemic stroke: a population‐based study in Rochester., Minnesota. Neurology 1996, 19, 154
- Ott A, 1997, Risk of Dementia.
- Chew W, 1991, Hyperglycemia augments ischemic brain injury., Am J Neuroradiol., 12, 603
- 10.1210/en.138.5.1886 · DOI
- 10.1210/jc.81.4.1657 · DOI
Cited by
Sorted by citations
Items 501–563 of 563
Stomby, A. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Mental Health and Cognitive Function
Sharp, P., Rogers, P. J., McNulty, H., & Fox, K. R. (2017) · Wiley eBooks · doi:10.1002/9781119141150.ch22 · Cited by 1
Damsma, M. L. (2009) · Utrecht University Repository (Utrecht University) · Cited by 1
Suvisaari, J., Perälä, J., Saarni, S. I., Härkänen, T., Pirkola, S., Joukamaa, M., Koskinen, S., Lönnqvist, J., & Reunanen, A. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0762-y · Cited by 68
“An potential confounder related to the association between diabetes and risperidone use in the elderly is somatic comorbidity, T2DM being associated with increased risk of dementia [44].”
BackgroundPsychiatric Care of the Patient with Diabetes
Kraker, J., & Ferrando, S. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_46
Nardin, P. (2006) · Americanae (AECID Library)
Nutritional and genetic determinants of cognitive ageing : a neuroepidemiological approach
Schiepers, O. J. G. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111221os
van Harten, B. (2006) · Data Archiving and Networked Services (DANS)
Estimation of polyphenol intake and the association with cognitive performance in UK women
Yahya, H. M. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Diabetes and the Consequences for the Blood‐Brain Barrier
Mooradian, A. D. (2006) · doi:10.1002/9783527611225.ch26
Psychologic Factors and Diabetes
Ryan, C. M. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch49
Kingma, A. W. (2012) · Utrecht University Repository (Utrecht University)
Murtishaw, A. S. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/6456429
Lunnon, K., Smith, R. G., Cooper, I., Greenbaum, L., Mill, J. S., & Beeri, M. S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.024
Medial temporal lobe atrophy on MRI: vascular risk factors and predictive value for dementia
Korf, E. S. C. (2006) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Determinants of Cognitive Decline and Dementia in the Very Old
Euser, S. M. (2008) · RePub (Erasmus University Rotterdam)
Salles, R. F. N. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-10052010-165804
Review Article Insulin resistance and pathological brain ageing
Cholerton, B., Baker, L. D., & Craft, S. (2011)
Takahashi, N. Y. (2016) · eScholarship (California Digital Library) · Cited by 1
Psychological and family characteristics of adolescents with type 2 diabetes
Mireles, G. (2012) · OakTrust (Texas A&M University Libraries)
Kour, H., Kothiwale, V., & Goudar, S. S. (2015) · Journal of the Scientific Society · doi:10.4103/0974-5009.165588
Tkachenko, O. V. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5281/zenodo.34006
“Клинически к ним относятся замедление темпа мышления, его инертность, снижение уровня абстрактно-логического мышления, нарушение осмысления и обработки информации, снижение способности к обучению; снижение слухоречевой и зрительной памяти [8, 10, 21, 25].”
Vascular Dementia After Stroke
Bogousslavsky, J., & Ghika, J. (2002) · CRC Press eBooks · doi:10.1201/9780203908884-12
Diabetes Mellitus and Depression as Risk Factors for Dementia: SADEM Study
Juárez‐Cedillo, T., Hsiung, G. R., Sepehry, A. A., Beattie, L. B., Jacova, C., & de la Peña, J. E. (2016) · InTech eBooks · doi:10.5772/64678
Unravelling the genetic components of late onset Alzheimer's disease.
Hamilton, G. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
The Effect of Docosahexaenoic Acid in a Mouse Model of Neuroinflammation
Orr, S. K. (2012) · TSpace (University of Toronto)
Rahmath, A. R., Krishnaprabha, P. S., Sana, V., Sureshkumar, P., & Sreekumaran, E. (2013) · Asian Journal of Health Sciences · doi:10.15419/ajhs.v1i1.428
Cognitive Function in Type 2 Diabetes: A Study Using Younger Adults
Lucas, K. (2017) · UEL Research Repository (University of East London) · doi:10.15123/pub.6748
“…last 15 years into diabetes has shown that in terms of cognitive impairment, processing speed is most typically affected by the presence of T2DM (Stewart & Liolitsa, 1999; Awad, Gagnon, & Messier, 2004; Manschot et al., 2006), although there is some suggestion that vascular complications e.g.…”
BackgroundAssociation between Dementia and Diabetes Mellitus : A Systematic Review
Mashi, H. M., Jaran, M. I., & Sumayli, A. M. T. (2017) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0042243
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.v1.i2.2018.55
Computational analysis of cerebrovascular structures imaged using two-photon microscopy
Dhiman, S., Singh, I., & Sarder, P. (2019) · SPIE Medical Imaging: Digital and Computational Pathology · doi:10.1117/12.2513234
Effect of palmatine hydrochloride on cognitive dysfunction in streptozotocin-induced diabetic Rats
Ahouei, M., Gh, V., Moghaddam, H. K., & Alamalhoda, F. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Ryan, C. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50102-5
Celebrating 50 years of Independence of Bangladesh
Soumendra, S. D. (2021) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs/ijlpr/sp15/oct/2021.1-25/s
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-3
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-2
Vascular Dementia After Stroke
Bogousslavsky, J., & Ghika, J. A. (2002) · Informa Healthcare eBooks · doi:10.1201/9780203908884.ch9
Min, J., Kang, C., Wasunkar, S., & Kim, H. (2021) · The Korean Journal of Public Health · doi:10.17262/kjph.2021.12.58.2.70
Diabetic Encephalopathy Affects Mitochondria and Axonal Transport Proteins
Eslami, M., Nahavandi, A., Nejad, T. B., & Roghani, M. (2019) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.460
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732579862.793572336
Samsuzzaman, M., Lee, J. H., Hong, S., Park, H. J., Chang, K., Kim, H.-B., Park, M. G., Eo, H., Oh, M. S., & Kim, S. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.29.534483
“505 Discussion 506 Numerous studies have found a relationship between hyperglycemia and brain dysfunction, 507 particularly depression, and behavioral flexibility in diabetic patients [54, 55, 56].”
BackgroundMohammad, N., Naaz, N., & Khan, N. (2023) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_36_22
Kour, H., Mishra, S. K., & Hattiholi, A. (2024) · Muller Journal of Medical Sciences and Research · doi:10.4103/mjmsr.mjmsr_76_23
Research Progress on Factors Related to Cognitive Function in Diabetes
曹, 惠. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482240
Ahrtz, L. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/175148
Schleicher, E. M., Tuchscher, J., Weber, M. M., Galle, P. R., Wörns, M.-A., Gairing, S. J., & Labenz, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316490
Panati, D., Madarapu, Y., Sibbala, B., Puthalapattu, S., & Gandla, S. D. (2025) · Archives of Mental Health · doi:10.4103/amh.amh_220_24
Xu, Z., Zhao, L., Yin, L., Cao, M., Liu, Y., Gu, F., Liu, X., & Zhang, G. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s480317
“4,5 It is important to accurately assess patients’ cognitive function to mitigate risk stratification and prognosis evaluation of the disease.”
Pramanik, A., Dutta, S., & Bhattacharyya, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00030-x
Cifuentes, M., Ramírez, E., Barahona, M. J., Martínez, F., de Lima, I., Ferrada, L., Bertinat, R., Ávila, F., Saldivia, N., Pérez‐Martín, M., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107225
Finns samband mellan riskfaktorer och subgrupper av Mild Cognitive Impairment
Nilsson, P., & Östberg, H. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Glucose Modulation of the Septo-Hippocampal System: Implications for Memory
Krebs‐Kraft, D. L. (2022) · doi:10.57709/1059900
Corraliza-Gómez, M., Bermejo, T., Lilue, J., Rodríguez-Iglesias, N., Valero, J., Cózar‐Castellano, I., Arranz, E., Sánchez, D., & Ganfornina, M. D. (2024) · Figshare · doi:10.6084/m9.figshare.26625493
Corraliza-Gómez, M., Bermejo, T., Lilue, J., Rodríguez-Iglesias, N., Valero, J., Cózar‐Castellano, I., Arranz, E., Sánchez, D., & Ganfornina, M. D. (2024) · Figshare · doi:10.6084/m9.figshare.26625496
Corraliza-Gómez, M., Bermejo, T., Lilue, J., Rodríguez-Iglesias, N., Valero, J., Cózar‐Castellano, I., Arranz, E., Sánchez, D., & Ganfornina, M. D. (2024) · Figshare · doi:10.6084/m9.figshare.26625490
Um, K., Kim, B. J., & Ying, G.-S. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110831
BindingDB (2016) · UC San Diego · doi:10.7270/q2rj4h7t
BindingDB Entry 50019411: Glycogen synthase kinase-3: A potential target for diabetes.
BindingDB (2024) · UC San Diego · doi:10.7270/q2rn3d6s
Post, H. W. A. (2009) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Stewart, R., & Liolitsa, D.
- Corresponding author
- Stewart, R.
- ORCID
- Stewart, R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 1999-02
- Volume
- 16
- Issue
- 2
- Pages
- 93-112
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2078868323
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 12 · 2020: 18 · 2019: 18 · 2018: 18 · 2017: 18 · 2016: 19 · 2015: 33 · 2014: 17 · 2013: 21 · 2012: 35
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- type 2 diabetes, cognitive impairment, dementia, vascular dementia, Alzheimer's disease, memory, executive function, hypertension, dyslipidemia, apolipoprotein E, dementia classification
- MeSH terms
- Cognition Disorders, Cross-Sectional Studies, Dementia, Diabetes Mellitus, Type 2, Humans, Population Surveillance, Prospective Studies, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
